//
Get monthly newsletter intelligence — trends, top movers, new opportunities
Newsletter Insights — advertising rates and audience data for 40K+ newsletters
Browse all →Advertisers are viewing this page. Claim it
Track COVID Intel - by William Makis (McGill Medicine)'s growth
Get notified when subscribers, engagement, or pricing changes
Platform Portability
Uses Substack subdomain (makisw.substack.com). Migrating would require subscribers to re-subscribe at a new address.
Custom domains let newsletters switch platforms without losing their audience.
Are you a newsletter creator? Get verified insights →
Cutting Edge Cancer Research, Repurposed Drugs in Cancer, Ivermectin, Mebendazole, Fenbendazole. Content is for informational purposes only. Entirely donation based. None of the information constitutes medical advice (see your doctor as needed).
Data updated Today
Avg Comments
26.6
Avg Likes
144.1
Engagement Rate
0.12%· ~171 likes + comments/post
(comments + likes) / subscribers
Typical for lists with 145K+ subscribers
Quality Score
Engagement vs Health
0.12% engagement rate
Score Breakdown
Engagement Score
| Public |
| What's more toxic: IVERMECTIN or ALCOHOL?CONCLUSION:Jul 14, 2026 | Public |
| RESEARCH for Parkinson's - CHLORELLAJul 14, 2026 | Subscriber-only |
| IVERMECTIN, FENBENDAZOLE, MELATONIN, CBD Oil Testimonial - 67 year old Pennsylvania woman with Stage 4 Small Cell Lung Cancer reports after 8 months: Cancer Free!Jul 13, 2026 | Subscriber-only |
| RESEARCH for Skin Disorders - SERRAPEPTASE for Inflammatory Skin Diseases (2025 South Korea)Jul 13, 2026 | Subscriber-only |
| RESEARCH for Skin Disorders - CHAGA Mushroom for Atopic Dermatitis (2026 Liu et al)Jul 13, 2026 | Subscriber-only |
| NEWS: WAR ON CANCER PATIENTS - Stolen and Altered Cancer Testimonials on Twitter are becoming a huge problem!There is a WAR on Cancer patients going on…Jul 12, 2026 | Public |
8.6K paid
Track revenue changes over time
Start tracking — freeTrack CPM rates as they change
Start tracking — freeSubscriber count is a platform estimate — actual growth not reflected in chart
vs 144 newsletters in Health
145K places you in the top 10% of newsletters in this category.
Engagement Rate
0.12%
median: 0.00%
Posts per Week
14.0
median: 1.0
Publishing Consistency
92/100
median: 66/100
Subscribers
145K
median: 1K
Here's what we know about this newsletter's activity:
Publishing Pace
Daily
Very Consistent
Category Rank
#8 of 806
in Health
Engagement Trend
Building
too early to measure
Nedra Nuggets
151K subs
Unbiased Science
129K subs
++0.5%/wk
Samantha Bee
127K subs
Get email alerts when subscribers drop or spike, when new sponsors appear, when pricing changes, or when publishing cadence shifts. Track unlimited newsletters across your watchlist with the Starter plan.
$29/mo·cancel anytime
See what's includedGet the full whitespace list with each brand's category fit, audience overlap, and recommended pitch order. Plus a comparison of COVID Intel - by William Makis (McGill Medicine) vs the top 15 peer newsletters on sponsor mix, growth, and CPM.
Including Momentous, Maui Nui Venison, Inside Tracker + 31 more.
$300·2-3 working days·refunded if we can't deliver
Publishing Frequency
Daily
Last published Jul 14, 2026
14.0 posts/week avg
Health Pricing
$6/mo median
Above average(+25%)
Monetization Readiness
Already monetizing
100% of similar-size Health newsletters also have paid tiers
Unlock revenue estimates, CPM benchmarks, and detected sponsors
Start tracking — free145.0K subscribers and 0.12% engagement — past the threshold where Health newsletters typically attract sponsors.
Consistent Publisher
Publishing consistency (92/100) is well above the Health median (66/100).